Related Experiment Videos
[Four gastrectomized cases associated with chronic leukemia]
Insights
Gastrectomy in chronic leukemia patients is feasible. Surgical outcomes were good, with no leukemia aggravation observed post-operation in these four cases.
Area of Science:
- Gastroenterology
- Hematology
- Surgical Oncology
Background:
- Chronic leukemia patients may require surgical intervention for gastrointestinal issues.
- Gastrectomy, a surgical removal of the stomach, presents unique management challenges in immunocompromised patients.
Observation:
- This study reviewed four cases of patients with chronic leukemia who underwent gastrectomy.
- The types of chronic leukemia included chronic myelogenous leukemia and hairy cell leukemia.
- Indications for gastrectomy were gastric cancer and bleeding gastric ulcers.
Findings:
- Subtotal gastrectomy was performed in all four patients.
- Splenectomy was also performed in three patients without complications.
- Patients experienced no significant management difficulties during or after surgery.
- The underlying leukemia condition did not worsen during the follow-up period.
Implications:
- Gastrectomy can be safely performed in select chronic leukemia patients.
- Careful perioperative management is crucial for successful outcomes.
- Further research is warranted to explore long-term outcomes and optimal surgical strategies.
Abstract:
We reviewed 4 gastrectomized cases associated with chronic leukemia. Three patients had chronic myelogenous leukemia, one had hairy cell leukemia. Subtotal gastrectomy was performed in all cases; two operations were for gastric cancer and two for bleeding gastric ulcers. The spleen was removed in three patients without any trouble. There were no difficulties in managing the patients during and after surgery and their leukemia was not aggravated during these periods.